Gsa Capital Partners LLP Cytom X Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.35 Billion
  • Q4 2024

A detailed history of Gsa Capital Partners LLP transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 38,885 shares of CTMX stock, worth $30,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,885
Holding current value
$30,330
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
BUY
$0.86 - $1.29 $33,441 - $50,161
38,885 New
38,885 $40,000
Q2 2024

Aug 15, 2024
BUY
$1.21 - $5.13 $97,436 - $413,098
80,526 Added 54.2%
229,093 $279,000
Q1 2024

May 03, 2024
BUY
$1.41 - $2.74 $62,611 - $121,669
44,405 Added 42.63%
148,567 $323,000
Q4 2023

Feb 16, 2024
BUY
$1.07 - $1.55 $111,453 - $161,451
104,162 New
104,162 $161,000
Q2 2023

Aug 14, 2023
BUY
$1.41 - $1.92 $485,278 - $660,804
344,169 New
344,169 $591,000
Q4 2021

Feb 14, 2022
SELL
$3.87 - $7.39 $964,195 - $1.84 Million
-249,146 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$4.32 - $6.43 $1.08 Million - $1.6 Million
249,146 New
249,146 $1.27 Million
Q2 2021

Aug 05, 2021
SELL
$6.33 - $9.91 $120,858 - $189,211
-19,093 Closed
0 $0
Q1 2021

May 10, 2021
SELL
$6.6 - $9.0 $84,222 - $114,849
-12,761 Reduced 40.06%
19,093 $148,000
Q4 2020

Feb 03, 2021
BUY
$6.47 - $7.9 $23,311 - $28,463
3,603 Added 12.75%
31,854 $209,000
Q3 2020

Nov 06, 2020
SELL
$6.55 - $8.83 $81,770 - $110,233
-12,484 Reduced 30.65%
28,251 $188,000
Q2 2020

Aug 11, 2020
SELL
$7.4 - $14.64 $153,039 - $302,769
-20,681 Reduced 33.67%
40,735 $339,000
Q1 2020

May 12, 2020
SELL
$3.61 - $8.6 $198,911 - $473,860
-55,100 Reduced 47.29%
61,416 $471,000
Q4 2019

Feb 12, 2020
BUY
$5.17 - $8.91 $199,143 - $343,204
38,519 Added 49.39%
116,516 $968,000
Q3 2019

Nov 12, 2019
BUY
$7.38 - $12.25 $90,788 - $150,699
12,302 Added 18.73%
77,997 $576,000
Q2 2019

Aug 06, 2019
BUY
$9.35 - $11.41 $280,845 - $342,722
30,037 Added 84.24%
65,695 $737,000
Q1 2019

May 15, 2019
BUY
$9.5 - $19.16 $9,101 - $18,355
958 Added 2.76%
35,658 $383,000
Q4 2018

Feb 12, 2019
SELL
$12.69 - $18.61 $2,538 - $3,722
-200 Reduced 0.57%
34,700 $524,000
Q3 2018

Nov 13, 2018
SELL
$18.04 - $26.41 $272,404 - $398,791
-15,100 Reduced 30.2%
34,900 $646,000
Q2 2018

Aug 09, 2018
BUY
$21.38 - $29.68 $880,150 - $1.22 Million
41,167 Added 466.06%
50,000 $1.14 Million
Q1 2018

May 11, 2018
BUY
$21.76 - $34.22 $192,206 - $302,265
8,833 New
8,833 $251,000

Others Institutions Holding CTMX

# of Institutions
71
Shares Held
46.1M
Call Options Held
3.7K
Put Options Held
4.7K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $51.4M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email